Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Drops By 74.6%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large decline in short interest during the month of January. As of January 30th, there was short interest totaling 1,382 shares, a decline of 74.6% from the January 15th total of 5,449 shares. Based on an average daily trading volume, of 15,250 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 15,250 shares, the days-to-cover ratio is currently 0.1 days.

Cardio Diagnostics Trading Down 0.6%

Cardio Diagnostics stock opened at $0.02 on Wednesday. The stock has a 50-day moving average of $0.02 and a two-hundred day moving average of $0.02. Cardio Diagnostics has a one year low of $0.01 and a one year high of $0.09.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.